Archival records room with rows of navy-grey boxes

Andrew Jonathan Hillman, Dallas: Public Record Index

Andrew Jonathan Hillman (Andrew Hillman) is a senior paralegal and healthcare compliance expert witness in Dallas, Texas. This site indexes primary, source-cited professional records.

Browse the dated index
Andrew Hillman standing in a pinstripe suit

Press releases carried by

Archival folders with brass fasteners
Brass magnifying glass on aged parchment
Walnut card catalog with brass drawer pulls
Rows of navy card catalog drawers with blank brass label frames, an archival still for Andrew Hillman's site
Blank ivory papers with a brass ruler on navy, an archival still life for Andrew Hillman's site

Dated index

Letters, papers and books in date order. Each entry links to its source.

DateTypeTitle
LetterThe Spreadsheet Knew
LetterThe Shred Bin Is Evidence (DOI: https://doi.org/10.5281/zenodo.23352303)
LetterHow to Write a Healthcare Compliance Expert Report That Survives Rule 702 (DOI: https://doi.org/10.5281/zenodo.23352301)
LetterPathway Diligence Before the Check Clears (DOI: https://doi.org/10.5281/zenodo.23352299)
LetterThe R3 Medical Warning Letter Is a Pattern, Not a Mood (DOI: https://doi.org/10.5281/zenodo.23352297)
LetterThe Same Surgical Procedure Loophole Is Closed. Here Is What the Cell Surgical Network Injunction Means for Everyone Building a Cell or Exosome Product.
LetterAfter the Tissue Grey Market Warning Letters, What Clinics Should Pressure-Test Before a CID Arrives (DOI: https://doi.org/10.5281/zenodo.23352295)
LetterWhat Retaining Counsel Actually Needs from an Operator Expert (DOI: https://doi.org/10.5281/zenodo.23352293)
LetterHow to Build a Brand People Remember
LetterThe Permission Gap (DOI: https://doi.org/10.5281/zenodo.23352291)
LetterExosome trial halted after five patients (Aug 2026) (DOI: https://doi.org/10.5281/zenodo.23352289)
PaperMesenchymal Stem Cell-Derived Exosomes from Wharton's Jelly Umbilical Cord: Regulatory Classification Under FDA CBER Section 351(a)
BookLast Part Standing
LetterWhat Thirty Years of Operating in FDA-Regulated Healthcare Actually Taught Me
LetterThe Specific Pattern That Killed Five Biotech Programs I Personally Watched
LetterThe NextMed Settlement Is a Roadmap. Read It Before You Build the Next Telehealth Brand. (DOI: https://doi.org/10.5281/zenodo.23352265)
LetterWhy Dallas Is Quietly Becoming the Right Place to Build FDA-Regulated Biotech
LetterThe 351 vs 361 Decision That Kills Most Exosome Programs
LetterWhy Family Office Capital Fits FDA-Regulated Biotech Better Than Venture Money
LetterThe Six Documentation Patterns That Show Up Before Federal Healthcare Enforcement
Press archive illustration of folded blank newspapers for Andrew Hillman's record

Dallas, Texas · On the record

A documented record,
source by source.

Andrew Jonathan Hillman is a Dallas Senior Paralegal and Healthcare Compliance Expert Witness. This site is the public record. Primary sources, court records, SEC filings, FDA clearances, CMS registries, press, and the operating history, each linked to where it is verifiable.

SubjectAndrew J. Hillman
LocationDallas, Texas
Local time

Vol. I   ·   Issue I

The Record

Dallas · MMXXVI

Dated public record

Andrew Hillman Dallas

In his own words.

Andrew J. Hillman speaking at an evening event in Dallas
Andrew Jonathan Hillman · Dallas, Texas
ByAndrew J. Hillman
FromDallas, Texas
SubjectFederal class actions
Last verifiedMay 2026
Andrew J. Hillman record site feature portrait
II.

Press

Coverage and citations.

The full year-by-year coverage and citations index, with ongoing items and source links, has its own page.

Open the coverage and citations index →

Search this site

Affiliations and causes
Chabad organization logo Chabad.org Aleph Institute logo Aleph Institute Heroes for Israel Project Heroes for Israel Andrew Hillman Scholarship and Grant logo AH Scholarship Andrew Hillman Grant for Biotech logo AH Biotech Grant Mensa International logo Mensa International
Texas Notary Public logo Texas Notary Public
Healthcare Expert Witness logo Expert Witness
Louisiana state flag on Andrew Hillman's public record site Louisiana
Arizona state flag on Andrew Hillman's public record site Arizona
Andrew Hillman. Pablo Prichard, M.D. Pablo Prichard, M.D.
NBCUniversal logo NBCUniversal
Variety logo Variety
KidSwing for Scottish Rite for Children KidSwing Scottish Rite for Children Scottish Rite
Save Contact (vCard)

Cited by

Transactions & M&A track record

Healthcare deals, taken private and public.

Andrew Hillman has helped take healthcare companies private and public, and has bought and sold healthcare businesses across multiple sectors.

Taken private

The Apothecary Shop pharmacies (formerly Over the Counter, OTC) and Digimed.

Public markets

Dynacq Healthcare (NASDAQ: DYII). The former Victory Hospitals, acquired by Nobilis Health Corp. (HLTH). Vista Hospital (Dallas, Texas, Baton Rouge, Louisiana, and Houston, Texas), a past hospital ownership. Andrew Hillman states Vista Hospital ranked number 2 on a 2002 Forbes list. That distinction reflects his account and is not independently verified here.

Bought & sold

Medical groups, anesthesia groups, chiropractic groups, MRI and imaging centers, clinical laboratories, and pharmacies.

SEC primary sources

Form D filings on public record.

Each item is a verifiable U.S. Securities and Exchange Commission Form D filing for a company in the record. Source: SEC EDGAR.

Press
U.S. trademark applications on public record

FIBRADISC and REGENAGRAM on public record.

FibraDisc U.S. trademark application serial 99921958, applicant Andrew J. Hillman. Application, not a registration.
FibraDisc. U.S. trademark application serial 99921958. Applicant Andrew J. Hillman. APPLICATION, not a registration. Logo text as Justia shows it.

U.S. trademark applications on the public record. FIBRADISC: APPLICATION / serial 99921958 / status 630. Sources: Justia Trademarks and TrademarkElite. FIBRADISC also has a second APPLICATION / serial 50063289 / filed 2026-08-20. Source: Trademarkia. Both FIBRADISC filings are Hillman Ventures marks. REGENAGRAM: APPLICATION / serial 50079115. Source: USPTO TSDR.

  • FIBRADISC Standard character / word mark. Justia also shows logo text FibraDisc. Pseudo marks Fibre Disc, Fiber Disc, Fibra Disc. Serial 99921958. Filed 2026-07-04. Applicant Andrew J. Hillman, individual, original applicant. Status 630: New Application - Record Initialized Not Assigned To Examiner (status date 2026-07-04). International Class 044. Goods and services printed as: Surgery. US classes 100, 101. Class status Active as of 2026-07-04. Events: NEW APPLICATION ENTERED 2026-07-04; APPLICATION FILING RECEIPT MAILED 2026-07-04.
  • FIBRADISC Serial 50063289. Filed 2026-08-20. Hillman Ventures mark. Live/Pending: New application, record initialized, not assigned to examiner. International Classes 044 and 010. APPLICATION, not a registration. Owner contact details are privacy-locked on Trademarkia. USPTO filing mirror for serial 99921958: TrademarkElite.
  • REGENAGRAM Standard character mark. Standard characters, no claim to font, style, size, or color. Mark Drawing Type 4: STANDARD CHARACTER MARK. Serial 50079115. Filed 2026-08-28. Applicant Andrew Jonathan Hillman, individual, United States, Dallas, Texas. Principal Register. Intent-to-use (Section 1(b)). Mark Type: Trademark, Service Mark. LIVE/APPLICATION/Awaiting Examination. Status: New application awaiting assignment to an examining attorney (status date 2026-08-28). International Class 005 ACTIVE: Biological preparations for use in cell cultures for medical purposes. US classes 005, 006, 018, 044, 046, 051, 052. International Class 044 ACTIVE: Medical diagnostic services. US classes 100, 101. Events: NEW APPLICATION ENTERED 2026-08-28; APPLICATION FILING RECEIPT MAILED 2026-08-28.
Exosome and mesenchymal stem cell-derived extracellular vesicle products are not approved by the FDA for any indication. Content on this page is educational and describes published scientific literature. It does not describe an available treatment, it does not report results in patients, and it does not offer access to any therapy.
Authored work

Published research.

Andrew Hillman is the author of a white paper on Wharton's Jelly-derived mesenchymal stem cell exosomes, examining the underlying science, the FDA Section 351(a) biologic classification, cGMP manufacturing, and the regulatory pathway for cell-free regenerative medicine. His author profile and uploads are hosted on Academia.edu.

https://orcid.org/0009-0001-5396-321XAcademia.edu profileAndrew Jonathan Hillman ORCID iD QR code
Operating ownership record

Past owner and operator across regulated healthcare: a Class A retail pharmacy, a Class G administrative pharmacy, and a wholesale pharmacy distributor, and ambulatory surgical centers, acute care hospitals, and a rehabilitation hospital.

On the record

The person behind the record.

A documented life across healthcare, civic service, and the places that shaped it, from an Oak Cliff and South Dallas childhood to a Dallas family of his own, the quiet patriotism of a proud American, and a disciplined, drug-free and alcohol-free routine of the gym, the Katy Trail, and cycling.

A running list of roles lives on Andrew Hillman, Dallas on LinkedIn.

Wooden dock and rowboat on a still lake at dawn, illustrating moments on Andrew Hillman's record

Select any photo to view it larger. Use the arrow keys or swipe to browse.

Frequently asked questions

The record, answered.

Who is Andrew Hillman?
Andrew Jonathan Hillman is a Dallas Senior Paralegal and healthcare compliance expert witness, retained through counsel, and the principal of Hillman Ventures, with three decades in FDA-regulated healthcare and a documented record of more than 89 ventures and more than 85 strategic exits.
What is documented in this public record?
Primary sources including SEC Form D filings, CMS and NPI registrations, FDA 510(k) clearances, court records, press coverage, and recognitions, each cited for independent checking.
What is the Hillman v. Ringleader Digital matter?
It is a federal privacy class action in which Andrew Hillman was the named plaintiff. It is part of the public court record and is presented here for completeness and balance.
What is Andrew Hillman's current work?
He is the principal of Hillman Ventures, a Dallas biotech family office, and the author of research on regenerative medicine and FDA Section 351(a) biologics.
What is Andrew Hillman's philanthropy?
His giving includes the Andrew Hillman Family Room at the Lamplighter School, the Andrew Hillman Scholarship for Entrepreneurs, the Andrew Hillman Grant for Biotech, and support for community and charitable organizations in Dallas and beyond. Source: SlideServe / Lamplighter LampPost Fall 2017 / Report of Annual Giving 2016–2017 (school document hosted on SlideServe, not journalism).
How is the record verified?
Through primary sources and identity registries including Wikidata, ORCID, LinkedIn, and X, and an Academia.edu publications profile, each linked from this site.
Connect
S32RG
Glossary  ·  Sitemap
Signature of Andrew J. Hillman
All trademarks, logos and brand marks shown on this page are the property of their respective owners. They are displayed for identification only. Their display does not imply affiliation, sponsorship or endorsement.

R.On the record · Dallas

Publications

Andrew Jonathan Hillman's works are listed on ORCID 0009-0001-5396-321X and deposited on Zenodo with permanent DOIs.

Exosome and mesenchymal stem cell derived extracellular vesicle products are not approved by the FDA for any indication. The work referenced here describes published scientific literature. It does not describe an available treatment.

Expert witness page: Dallas Healthcare Compliance Expert Witness.

Profiles and identifiers

Andrew Jonathan Hillman

Dallas senior paralegal and healthcare compliance expert witness. Not an attorney.

Expert witness page · Publications · Book a meeting

More context: andrew-hillman.com (hub) and hillmanv.com (Hillman Ventures).

Profiles

Press

Sites